Identification of tRNAs incorporated into wild-type and mutant human immunodeficiency virus type 1
about
tRNAs promote nuclear import of HIV-1 intracellular reverse transcription complexesHuman immunodeficiency virus type 1 (HIV-1) viral protein R (Vpr) interacts with Lys-tRNA synthetase: implications for priming of HIV-1 reverse transcription.Incorporation of lysyl-tRNA synthetase into human immunodeficiency virus type 1Inhibition of tRNA₃(Lys)-primed reverse transcription by human APOBEC3G during human immunodeficiency virus type 1 replicationReduced replication of human immunodeficiency virus type 1 mutants that use reverse transcription primers other than the natural tRNA(3Lys)The connection domain in reverse transcriptase facilitates the in vivo annealing of tRNALys3 to HIV-1 genomic RNAThe Host RNAs in Retroviral ParticlesHost RNA Packaging by Retroviruses: A Newly Synthesized StorySelective unfolding of one Ribonuclease H domain of HIV reverse transcriptase is linked to homodimer formationOrchestrating the Selection and Packaging of Genomic RNA by Retroviruses: An Ensemble of Viral and Host FactorsMutated K65R recombinant reverse transcriptase of human immunodeficiency virus type 1 shows diminished chain termination in the presence of 2',3'-dideoxycytidine 5'-triphosphate and other drugsRole of Pr160gag-pol in mediating the selective incorporation of tRNA(Lys) into human immunodeficiency virus type 1 particles.Primer tRNAs for reverse transcriptionTransportin 3 promotes a nuclear maturation step required for efficient HIV-1 integration.Inability of human immunodeficiency virus type 1 produced in murine cells to selectively incorporate primer formula.The role of Pr55(gag) in the annealing of tRNA3Lys to human immunodeficiency virus type 1 genomic RNACyclic peptide inhibitors of HIV-1 capsid-human lysyl-tRNA synthetase interactionThe nucleocapsid protein specifically anneals tRNALys-3 onto a noncomplementary primer binding site within the HIV-1 RNA genome in vitro.tRNA synthetase: tRNA aminoacylation and beyondEffect of polypurine tract (PPT) mutations on human immunodeficiency virus type 1 replication: a virus with a completely randomized PPT retains low infectivity.The requirement for the highly conserved G-1 residue of Saccharomyces cerevisiae tRNAHis can be circumvented by overexpression of tRNAHis and its synthetase.Proteolytic processing of the p2/nucleocapsid cleavage site is critical for human immunodeficiency virus type 1 RNA dimer maturation.Role for human immunodeficiency virus type 1 Tat protein in suppression of viral reverse transcriptase activity during late stages of viral replication.Mechanistic differences between nucleic acid chaperone activities of the Gag proteins of Rous sarcoma virus and human immunodeficiency virus type 1 are attributed to the MA domain.Functional recognition of the modified human tRNALys3(UUU) anticodon domain by HIV's nucleocapsid protein and a peptide mimic.Nonrandom packaging of host RNAs in moloney murine leukemia virusEffect of altering the tRNA(Lys)(3) concentration in human immunodeficiency virus type 1 upon its annealing to viral RNA, GagPol incorporation, and viral infectivity.Similarities and differences in the nucleic acid chaperone activity of HIV-2 and HIV-1 nucleocapsid proteins in vitroMatrix domain modulates HIV-1 Gag's nucleic acid chaperone activity via inositol phosphate binding.Psoralen crosslinking between human immunodeficiency virus type 1 RNA and primer tRNA3(Lys)Cleavage of the HIV replication primer tRNALys,3 in human cells expressing bacterial anticodon nucleaseRole of HIV-1 nucleocapsid protein in HIV-1 reverse transcription.HIV-1 modulates the tRNA pool to improve translation efficiency.The conformation of the mature dimeric human immunodeficiency virus type 1 RNA genome requires packaging of pol protein.Mapping the small RNA content of simian immunodeficiency virions (SIV)Cellular distribution of Lysyl-tRNA synthetase and its interaction with Gag during human immunodeficiency virus type 1 assembly.A retrovirus packages nascent host noncoding RNAs from a novel surveillance pathwayViral hijacking of mitochondrial lysyl-tRNA synthetase.Generation and characterization of a SIVmac239 clone corrected at four suboptimal nucleotides.Human Endogenous Retrovirus Type K (HERV-K) Particles Package and Transmit HERV-K-Related Sequences
P2860
Q21146036-9499AEEA-1B4F-4DD1-BC94-5BA4A8AF8BB8Q24523263-C0CE26CB-D216-4CD6-B303-946503207081Q24529517-E9DAF484-822F-4FDA-A24B-CC281BE8AFEEQ24669993-205B2DDA-72B9-4519-82A4-A3288BCDB91EQ24675393-5CF63112-308E-4E48-B899-E7CBBE796E30Q24806162-34C66D0F-DD8D-495B-9E81-F13F2D8BA44AQ26739938-1F379258-D889-4F3C-BDC7-41DE5751BF69Q26767304-3BC40240-93A6-4E04-ABDF-130D09CFAEA3Q27681926-8406D35C-E0C8-4338-A9AE-2D8EF3EB6AF2Q28074165-576541AB-4884-460E-80F4-78DB3393BD24Q28367663-C0690068-3A67-465F-B71F-7D66AE5B80DCQ28646824-DE8C6B2F-2E0B-4532-B5BF-C1270FCD71A0Q28775697-BFBBC498-51AE-45D8-996F-5C441BDF94E7Q30406846-55C7AEE7-6E0A-4248-8D07-BF461F14E987Q30439541-F1F106DC-4D80-4899-8615-15B427CC577DQ30453508-65CA6602-6982-4849-AB2A-BF4869F6717CQ31046491-B8333B2D-96A7-4673-8253-70CA2A7B2E1AQ33709362-70A0B8D0-68FB-474B-B02D-7AE46B0F55BCQ33774299-B6A11C83-FFAF-4BF2-9E06-77A5DC32A9C5Q33788773-4E969508-5DBF-4223-9DDE-1CEE0F4800D3Q33799095-748F6103-4173-456A-B8B7-FC2829A4F397Q33845445-A51D54B2-40DA-48F6-9671-07AC220515F7Q33865436-94336723-A77D-4B4D-BA1C-A6EC632EDC8FQ33900316-F9F470CF-EC54-470F-8B2F-F1B1BF211ACFQ33962718-3093D975-886F-4390-B678-8AFE05399C93Q34092811-393D8D94-E48D-4B4F-8E86-CD91C96FA788Q34344599-8886CAAC-230D-47F7-8828-2C62DAB0DEB9Q34486061-4C1FDB29-3A68-479F-BE97-E12239BAF25EQ34529887-666C5F3A-DB08-41A5-8A43-DBCD21F89403Q34588935-0CAD2325-AFBF-417E-9EE6-090685242410Q34751283-EDBB5C31-A366-446C-844D-4F7B070CF557Q34775658-D985B538-FE37-4CF4-AA0E-C6C791E23CF0Q34994062-69A29C88-F738-4D59-ADF8-1E4EAC0C0F65Q34999802-6BC1F104-465D-4D22-8B4E-8B563CBA3910Q35005372-F1A7F7FA-16BF-4D81-8FFC-46F0DF76D932Q35123403-8BF0709D-8029-4AA9-8331-8338E8619FA9Q35228751-DC3507A2-9D8E-47E3-AFF2-8DAA57C17AC1Q35634277-B439BAC4-BCF9-4895-AFAD-748B6D214877Q35748138-073A6CCF-596F-42C2-8705-9CFFBA03D968Q35758600-BD6EE74E-6402-4D34-B9BC-72198ADDF629
P2860
Identification of tRNAs incorporated into wild-type and mutant human immunodeficiency virus type 1
description
1993 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
1993 թվականի հունիսին հրատարակված գիտական հոդված
@hy
artículu científicu espublizáu en 1993
@ast
im Juni 1993 veröffentlichter wissenschaftlicher Artikel
@de
scientific journal article
@en
vedecký článok (publikovaný 1993/06/01)
@sk
vědecký článek publikovaný v roce 1993
@cs
wetenschappelijk artikel (gepubliceerd op 1993/06/01)
@nl
наукова стаття, опублікована в червні 1993
@uk
مقالة علمية (نشرت في يونيو 1993)
@ar
name
Identification of tRNAs incorp ...... immunodeficiency virus type 1
@ast
Identification of tRNAs incorp ...... immunodeficiency virus type 1
@en
Identification of tRNAs incorp ...... immunodeficiency virus type 1
@nl
type
label
Identification of tRNAs incorp ...... immunodeficiency virus type 1
@ast
Identification of tRNAs incorp ...... immunodeficiency virus type 1
@en
Identification of tRNAs incorp ...... immunodeficiency virus type 1
@nl
prefLabel
Identification of tRNAs incorp ...... immunodeficiency virus type 1
@ast
Identification of tRNAs incorp ...... immunodeficiency virus type 1
@en
Identification of tRNAs incorp ...... immunodeficiency virus type 1
@nl
P2093
P2860
P3181
P1433
P1476
Identification of tRNAs incorp ...... immunodeficiency virus type 1
@en
P2093
P2860
P304
P3181
P50
P577
1993-06-01T00:00:00Z